DENVER, CO / ACCESSWIRE / July 12, 2016 / MediJane Holdings, Inc. ("MediJane") a publicly-traded company (OTC: MJMD), operating as a wholesaler and product distribution company within the legalized cannabis industries, is pleased to announce the appointment of NMS Capital Advisors, LLC ("NMS"), a registered broker dealer headquartered in Beverly Hills, California. NMS is registered with the Securities and Exchange Commission and the Financial Regulatory Authority to act as the Company's exclusive financial advisor banker. NMS shall advise the Company on its current plans involving industry repositioning, expansion, acquisitions and a greater access to the capital markets.
Core objectives of MediJane's 2016 strategic plan include its positioning for long-term financing, significantly increasing revenues, and enhancing value to our shareholders. The board of directors believes it to be in the best short-term and long-term interests of the shareholders to focus MediJane's energy and resources on creating medical products infused with cannabidiol (CBD), rather than traditional medical marijuana products at this time.
MediJane has limited its business scope to only products containing CBD derived from industrial hemp, as defined in the 2014 U.S. Farming Bill. These products are required to contain less than 0.3% tetra-hydra-cannabinol (THC). The focus of these products remains on clinically-oriented delivery systems for products infused with cannabinoids.
Founded in 2006, NMS Capital Advisors is a leading global focused investment banking and advisory firm providing an array of Global Capital Advisory™ services which include M&A, Corporate Finance and Strategic Advisory services to both public and private clients located in the United States, Asia and Europe. The NMS Capital Investment Banking consists of seasoned professionals with in-depth domestic and international capital markets transaction experience.
NMS will be working with the Company's senior management on the Company's strategic growth and business plan, including strategic acquisitions, corporate roll ups and expanding capital raising efforts. Specifically, NMS will advise the Company on various financing strategies and alternatives regarding its current capitalization plan. Documents prepared by NMS will be circulated to potential strategic investors via Private Investment Firms and/or Investment Banking Firms.
Lewis Humer, Chairman of MediJane, said, "Our engagement with NMS Capital Advisors serves as a significant landmark in the Company's progression and application of our internal business and corporate strategy plan. This engagement substantiates the fundamental value of MediJane to our existing shareholders. We are looking forward to the advice and direction from Trevor M. Saliba and the NMS team. We believe that through NMS, we will accelerate growth strategies including key target acquisitions, roll-ups, and capital raising."
Trevor M. Saliba, Chairman and Chief Executive Officer of NMS Capital Advisors LLC, said, "We are thrilled to be a part of a cutting edge, emerging market, where we believe that we can assist MediJane with their mid term and long term goals. Working as the broker dealer and investment bank for MediJane, one of our primary goals is to drive capital expansion which will enable MediJane to accelerate business expansion."
About MediJane Holdings Inc. (MJMD)
MediJane is in the business of marketing and distributing products within the legal medical cannabis industry, including transdermal patches, capsules, sublingual sprays, oral strips, and other medical products infused with cannabidiol (CBD). MediJane products give doctors, medical professionals and patient advocates the ability to provide patients accurate doses of cannabinoids to manage and treat pain and other specific illnesses.
For more information, visit www.medijane.co.
MediJane Holdings Inc.
SOURCE: MediJane Holdings Inc.